Trevena Executives
TRVNDelisted Stock | USD 1.98 0.18 10.00% |
Trevena employs about 23 people. The company is managed by 9 executives with a total tenure of roughly 23 years, averaging almost 2.0 years of service per executive, having 2.56 employees per reported executive. Analysis of Trevena's management performance can provide insight into the firm performance.
Mark Demitrack President Senior Vice President and Chief Medical Officer |
Robert Yoder President Senior Vice President and Chief Business Officer |
Trevena |
Trevena Management Team Effectiveness
The company has return on total asset (ROA) of (0.7151) % which means that it has lost $0.7151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.1458) %, meaning that it created substantial loss on money invested by shareholders. Trevena's management efficiency ratios could be used to measure how well Trevena manages its routine affairs as well as how well it operates its assets and liabilities.Trevena Workforce Comparison
Trevena is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 187. Trevena retains roughly 23.0 in number of employees claiming about 12% of equities under Health Care industry.
Trevena Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Trevena insiders, such as employees or executives, is commonly permitted as long as it does not rely on Trevena's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Trevena insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Carrie Bourdow over a month ago Disposition of 1055 shares by Carrie Bourdow of Trevena at 1.47 subject to Rule 16b-3 | ||
Moulder Leon O Jr over two months ago Acquisition by Moulder Leon O Jr of 100000 shares of Trevena at 0.43 subject to Rule 16b-3 | ||
Barry Shin over two months ago Disposition of tradable shares by Barry Shin of Trevena at 5.95 subject to Rule 16b-3 | ||
Robert Yoder over two months ago Disposition of 443 shares by Robert Yoder of Trevena at 1.55 subject to Rule 16b-3 | ||
Johnson Marvin over three months ago Acquisition by Johnson Marvin of 13700 shares of Trevena at 0.4 subject to Rule 16b-3 | ||
Mark Demitrack over six months ago Disposition of 30601 shares by Mark Demitrack of Trevena at 0.65 subject to Rule 16b-3 | ||
Barbara Yanni over six months ago Acquisition by Barbara Yanni of 100000 shares of Trevena subject to Rule 16b-3 | ||
David Soergel over six months ago Purchase by David Soergel of 1250 shares of Trevena |
Trevena Notable Stakeholders
A Trevena stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Trevena often face trade-offs trying to please all of them. Trevena's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Trevena's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark Demitrack | Senior Vice President and Chief Medical Officer | Profile | |
Robert Yoder | Senior Vice President and Chief Business Officer | Profile | |
Carrie Bourdow | Senior Vice President Chief Commercial Officer | Profile | |
Barry Shin | Senior CFO | Profile | |
Joel Solomon | General VP | Profile | |
Michael Catalano | Vice Marketing | Profile | |
Howard MD | Consultant Founder | Profile | |
Mark MD | Senior Officer | Profile | |
Patricia Drake | Senior Officer | Profile |
About Trevena Management Performance
The success or failure of an entity such as Trevena often depends on how effective the management is. Trevena management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Trevena management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Trevena management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. Trevena operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
Trevena Workforce Analysis
Traditionally, organizations such as Trevena use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Trevena within its industry.Trevena Manpower Efficiency
Return on Trevena Manpower
Revenue Per Employee | 135.9K | |
Revenue Per Executive | 347.2K | |
Net Loss Per Employee | 1.8M | |
Net Loss Per Executive | 4.5M | |
Working Capital Per Employee | 1.4M | |
Working Capital Per Executive | 3.6M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Trevena Stock
If you are still planning to invest in Trevena check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Trevena's history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |